Chevron

The Supreme Court’s Self-Coronation

The Supreme Court’s Self-Coronation

The U.S. Supreme Court’s current docket presents the Court with more opportunities to empower itself at the expense of other governmental institutions.

On Misciting Marbury

On Misciting Marbury

In deciding whether to overrule the Chevron doctrine, the Supreme Court should not be persuaded by mistaken invocations of a famous dictum.

Supreme Court To Hear Case Endangering the Chevron Doctrine

Supreme Court To Hear Case Endangering the Chevron Doctrine

A dispute over fishery regulation could deliver a blow to a key doctrine calling for deference to administrative agencies.

Chevron’s Watery Grave?

Chevron’s Watery Grave?

A fight over fishery regulations could spell trouble for Chevron deference.

Guidance for Regulators on the Major Questions Doctrine

Guidance for Regulators on the Major Questions Doctrine

To avoid potential legal challenges, agencies should take even more care in their regulatory planning, review, and communication.

Another Round of Speculation about Chevron?

Another Round of Speculation about Chevron?

An upcoming SCOTUS case provides an opening for greater dispute over the power of regulatory agencies.

Is Chevron Deference Still Alive?

Is Chevron Deference Still Alive?

Three takeaways follow from the Supreme Court’s recent opinions ignoring Chevron v. NRDC.

The Supreme Court’s 2021-2022 Regulatory Term

The Supreme Court’s 2021-2022 Regulatory Term

Scholars and practitioners discuss the Court’s most significant regulatory decisions of the last term.

Did Step Zero Help Doom Chevron?

Did Step Zero Help Doom Chevron?

One of the Supreme Court’s most significant administrative law precedents may soon be overturned.

Threatening Chevron Deference Threatens Government as a Whole

Threatening Chevron Deference Threatens Government as a Whole

Scholar argues that overruling deference to agencies will constrain U.S. government action.

Medicare and Chevron in the Supreme Court’s New Term

Medicare and Chevron in the Supreme Court’s New Term

With two Medicare cases, the U.S. Supreme Court may change an important rule on deference to agency decisions.

Regulatory Reactivity in FDA’s Approval of Aduhelm

Regulatory Reactivity in FDA’s Approval of Aduhelm

A controversial approval of an Alzheimer’s treatment reveals a core weakness in oversight of agency discretion.